Dr Vincent Cheung

Dr Vincent Cheung is a Consultant Gastroenterologist at Oxford University Hospitals NHS Foundation Trust, as well as The Manor Hospital and New Foscote Hospital. He is a Regional Clinical Advisor in Gastroenterology for NHS England South East Region.

He provides evidence-based, personalised care for patients with a wide range of gastrointestinal conditions and is highly regarded for his empathetic approach, clear communication, and commitment to delivering excellent patient care.

After graduating from the University of Cambridge, Dr Cheung completed his medical training at King's College London. He subsequently undertook specialist training in London and Oxford and completed an advanced fellowship at the Royal Free GI Neuroendocrine Tumour Unit.

Dr Cheung has expertise in the diagnosis and management of a broad spectrum of gastrointestinal disorders, including acid reflux, swallowing difficulties, abdominal pain, bloating, nausea, vomiting, diarrhoea, constipation, rectal bleeding, anaemia, and symptoms associated with irritable bowel syndrome. His specialist interests include inflammatory bowel disease (IBD), cancer immunotherapy-related gastrointestinal complications, gastrointestinal adverse events, and advanced endoscopic procedures.

He is an accredited Bowel Cancer Screening colonoscopist and leads the weekly IBD surveillance multidisciplinary team meeting at Oxford University Hospitals. He also directs a tertiary gastrointestinal liaison service for immune-related adverse events, supporting patients receiving cancer immunotherapy at the Oxford Cancer Centre and other regional centres.

Alongside his clinical practice, Dr Cheung is actively involved in research. His work on immunotherapy-related gastrointestinal and liver adverse events has been published in leading medical journals, including Gastroenterology, Gut, the British Journal of Cancer, and Frontline Gastroenterology. His current research interests include IBD surveillance, immune checkpoint inhibitor colitis, and the application of artificial intelligence in gastrointestinal healthcare. He is also a principal investigator on several clinical trials conducted through the Oxford IBD Clinical Trials Facility, contributing to advances in the treatment and management of inflammatory bowel disease.